K042389 is an FDA 510(k) clearance for the MODIFICATION TO PRECINORM UNIVERSAL PLUS AND PRECIPATH UNIVERSAL PLUS CONTROL SERA. This device is classified as a Multi-analyte Controls, All Kinds (assayed) (Class I - General Controls, product code JJY).
Submitted by Roche Diagnostics Corp. (Indianapolis, US). The FDA issued a Cleared decision on September 14, 2004, 12 days after receiving the submission on September 2, 2004.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1660.